{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:23Z","timestamp":1786372943979,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.2215\/cjn.08431109","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T21:11:23Z","timestamp":1274994683000},"page":"1506-1512","source":"Crossref","is-referenced-by-count":7,"title":["Unusual Pattern of Dyslipidemia in Children Receiving Steroid Minimization Immunosuppression after Renal Transplantation"],"prefix":"10.2215","volume":"5","author":[{"given":"Keith K.","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard V.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavjay","family":"Butani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20230601","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005792-199407000-00004","article-title":"Hyperlipidemia in renal transplant recipients: Natural history and response to treatment","volume":"73","author":"Ong","year":"1994","journal-title":"Medicine (Baltimore"},{"key":"R2-22-20230601","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","article-title":"Hyperlipidemia in solid organ transplantation","volume":"63","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"key":"R3-22-20230601","first-page":"S81","article-title":"Dyslipidemia and its management after renal transplantation","volume":"14","author":"Andany","year":"2001","journal-title":"J Nephrol"},{"key":"R4-22-20230601","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1681\/ASN.V212s238","article-title":"Hyperlipidemia and transplantation: Etiologic factors and therapy","volume":"2","author":"Pirsch","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"R5-22-20230601","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0012.2004.00160.x","article-title":"A long-term study on hyperlipidemia in stable renal transplant recipients","volume":"18","author":"Tse","year":"2004","journal-title":"Clin Transplant"},{"key":"R6-22-20230601","first-page":"39","article-title":"Studies on post-transplant dyslipidemia in kidney transplant patients","volume":"54","author":"Marubayashi","year":"2005","journal-title":"Hiroshima J Med Sci"},{"key":"R7-22-20230601","first-page":"176","article-title":"Cardiovascular disease after renal transplantation","volume":"20","author":"Kasiske","year":"2000","journal-title":"Semin Nephrol"},{"key":"R8-22-20230601","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/00007890-199605270-00010","article-title":"The effect of pravastatin on acute rejection after kidney transplantation\u2014a pilot study","volume":"61","author":"Katznelson","year":"1996","journal-title":"Transplantation"},{"key":"R9-22-20230601","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1399-3046.2003.00036.x","article-title":"Pilot study describing the use of pravastatin in pediatric renal transplant recipients","volume":"7","author":"Butani","year":"2003","journal-title":"Pediatr Transplant"},{"key":"R10-22-20230601","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1399-3046.2005.00373.x","article-title":"Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation","volume":"9","author":"Butani","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R13-22-20230601","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: Predicting risks by levels and ratios","volume":"121","author":"Kinosian","year":"1994","journal-title":"Ann Intern Med"},{"key":"R14-22-20230601","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-8703(02)94701-0","article-title":"Role of lipid and lipoprotein profiles in risk assessment and therapy","volume":"146","author":"Ballantyne","year":"2003","journal-title":"Am Heart J"},{"key":"R15-22-20230601","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2007-1472","article-title":"Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: The Bogalusa Heart Study","volume":"121","author":"Frontini","year":"2008","journal-title":"Pediatrics"},{"key":"R16-22-20230601","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1053-2498(01)00251-0","article-title":"Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients","volume":"20","author":"Penson","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R17-22-20230601","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00467-002-0860-z","article-title":"Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients","volume":"17","author":"Krmar","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"R18-22-20230601","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1399-3046.2003.02048.x","article-title":"Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients","volume":"7","author":"Argent","year":"2003","journal-title":"Pediatr Transplant"},{"key":"R19-22-20230601","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00467-007-0660-6","article-title":"Diet does not explain the high prevalence of dyslipidaemia in paediatric renal transplant recipients","volume":"23","author":"Siirtola","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R20-22-20230601","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11255-007-9266-y","article-title":"Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function","volume":"40","author":"Perrea","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"R21-22-20230601","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ajhp\/61.6.565","article-title":"Drug-related dyslipidemia after renal transplantation","volume":"61","author":"Mathis","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R22-22-20230601","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0012.1997.tb00810.x","article-title":"Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients","volume":"11","author":"Hohage","year":"1997","journal-title":"Clin Transplant"},{"key":"R23-22-20230601","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/S0041-1345(98)01301-3","article-title":"Hypertriglyceridemia in renal transplant recipients treated with sirolimus","volume":"30","author":"Brattstr\u00f6m","year":"1998","journal-title":"Transplant Proc"},{"key":"R24-22-20230601","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/S0041-1345(03)00241-0","article-title":"Sirolimus European Renal Transplant Study Group: Cardiovascular risk factors of sirolimus compared with cyclosporine: Early experience from two randomized trials in renal transplantation","volume":"35","author":"Legendre","year":"2003","journal-title":"Transplant Proc"},{"key":"R25-22-20230601","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.transproceed.2005.03.152","article-title":"Lipid metabolism in renal transplant patients receiving tacrolimus\/sirolimus combination therapy","volume":"37","author":"Wlodarczyk","year":"2005","journal-title":"Transplant Proc"},{"key":"R26-22-20230601","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.1996.401","article-title":"Left ventricular abnormalities in children, adolescents and young adults with renal disease","volume":"50","author":"Johnstone","year":"1996","journal-title":"Kidney Int"},{"key":"R27-22-20230601","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mpd.2002.125910","article-title":"Cardiovascular mortality in children and young adults with end-stage kidney disease","volume":"141","author":"Parekh","year":"2002","journal-title":"J Pediatr"},{"key":"R28-22-20230601","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.transproceed.2006.02.004","article-title":"Predictors of cardiovascular events and associated mortality of kidney transplant recipients","volume":"38","author":"Fazelzadeh","year":"2006","journal-title":"Transplant Proc"},{"key":"R29-22-20230601","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R30-22-20230601","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI112327","article-title":"Dexamethasone modulates lipoprotein metabolism in cultured human monocyte-derived macrophages. Stimulation of scavenger receptor activity","volume":"77","author":"Hirsch","year":"1986","journal-title":"J Clin Invest"},{"key":"R31-22-20230601","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.1981.62","article-title":"Lipid abnormalities in uremia, dialysis, and transplantation","volume":"19","author":"Chan","year":"1981","journal-title":"Kidney Int"},{"key":"R32-22-20230601","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1399-0012.2005.00341.x","article-title":"Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus","volume":"19","author":"Imamura","year":"2005","journal-title":"Clin Transplant"},{"key":"R33-22-20230601","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.transproceed.2007.10.008","article-title":"Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen","volume":"39","author":"Lisik","year":"2007","journal-title":"Transplant Proc"},{"key":"R34-22-20230601","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0022-2275(20)41339-2","article-title":"Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: Role in dyslipidemia","volume":"33","author":"Moulin","year":"1992","journal-title":"J Lipid Res"},{"key":"R35-22-20230601","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00046-3","article-title":"Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia","volume":"320","author":"Salazar","year":"2002","journal-title":"Clin Chim Acta"},{"key":"R36-22-20230601","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1046\/j.1523-1755.2002.00611.x","article-title":"Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients","volume":"62","author":"Lemieux","year":"2002","journal-title":"Kidney Int"},{"key":"R37-22-20230601","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"R38-22-20230601","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-8703(00)90033-4","article-title":"Statins: Effective antiatherosclerotic therapy","volume":"139","author":"Blumenthal","year":"2000","journal-title":"Am Heart"},{"key":"R39-22-20230601","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1194\/jlr.P002816","article-title":"Effect of statins on HDL: A complex process unrelated to changes in LDL: Analysis of the VOYAGER database","volume":"51","author":"Barter","year":"2010","journal-title":"J Lipid Res"},{"key":"R40-22-20230601","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMoa031766","article-title":"Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol","volume":"350","author":"Brousseau","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201008000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:48Z","timestamp":1786369188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201008000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08431109","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}